AI assistant
Ion Exchange (India) Ltd — Investor Presentation 2021
Jun 10, 2021
61696_rns_2021-06-10_f2344292-e52a-40d2-a4a7-4120e35557f6.pdf
Investor Presentation
Open in viewerOpens in your device viewer
==> picture [214 x 53] intentionally omitted <==
June 10, 2021
To, BSE Limited The Corporate Relationship Dept. P.J. Towers, Dalal Street, Mumbai – 400 001
BSE Company Code: 500214
Dear Sir/ Madam,
Sub: Submission of Analyst / Investor Presentation
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed presentation being made to Analyst / Institutional Investor to discuss the Financial performance of the Company for the year Ended March 31, 2021.
The aforesaid information is also disclosed on website of the company i.e. www.ionindia.com
Kindly take the information on record.
Thanking You,
Yours faithfully,
For Ion Exchange (India) Limited
MILIND Digitally signed by MILIND DATTATRAYA DATTATRAY PURANIK Date: 2021.06.10 A PURANIK 09:47:08 +05'30'
Milind Puranik Company Secretary
==> picture [469 x 40] intentionally omitted <==
EARNINGS PRESENTATION – Q4-FY21 / FY21
Executive Summary
OVERVIEW
FY21: Operating Income* INR 14,495 Mn
-
Ion Exchange (India) Ltd (Ion Exchange), formed in 1964, is a pioneer in water, waste water treatment & environment solutions and caters to various industries, institutions, homes & communities.
-
Headquartered in Mumbai, the company has seven manufacturing & assembly facilities across India, and one each in Bangladesh, UAE, Bahrain and Indonesia. It also has presence across other key geographies.
-
Installation: 100,000 + globally; 1000+ in core sectors.
BUSINESS & FY21 REVENUE MIX (%) - MARQUEE CLIENTS CONSOLIDATED
FY21: PAT* INR 1,433 Mn
• Engineering (63%) – Provides comprehensive and FY21: Operating EBITDA integrated services and solutions in water & waste water treatment including Sea Water desalination, INR 2,023 Recycle and Zero liquid discharge plants to diverse Mn* industries.
-
Chemicals (30%) – Provides a comprehensive range of resins, speciality chemicals and customized chemical treatment programmes for water, nonwater and specialty applications.
-
Consumer Products (7%) – Caters to individuals, hotels, spas, educational institutions, hospitals, laboratories, railway and defence establishments providing safe drinking water and a clean environment.
*Consolidated
-
Industrial – NTPC, NPC, Reliance, IOCL, JSW, CPCL, L&T, Arcelormittal Nippon Steel, Nayara Energy, IRCTC , BHEL, Tata Group.
-
Institutional – Leela, Military Engineering Services, Taj Hotels, Holiday Inn, Hyatt Regency, Oberoi Hotels, Apollo Hospitals, Escorts Heart Institute, DLF, Puravankar.
-
International – Cargill, Technip France, Unilever Group, Jurong, Thyssenkrupp (Uhde), Jacobs, Kawasaki, Mitsubishi, PDO Oman, Emirates Steel, IKPP Indonesia.
2
Company Overview
-
Ion Exchange was originally formed as a subsidiary of Permutit, UK in 1964. It became a wholly owned Indian company in 1985. The company is currently in its 56[th] Year of operations.
-
The company has expanded its footprints globally and possesses a diversified product range. It offers one stop water and non-water treatment solutions catering to diverse segments like infrastructure, industry, institutions, municipalities, homes and communities, urban and rural.
-
The company offers a wide range of solutions across the water cycle from pretreatment to process water treatment, waste water treatment, recycle, zero liquid discharge, sewage treatment, packaged drinking water, sea water desalination etc.
-
The company is also engaged in manufacturing ion exchange resins, membranes, speciality chemicals for water and waste water treatment as well as non-water applications.
-
It has two facilities for in-house R&D and two applications and testing centers.
-
The company has over 50 patents to their credit and 100+ products commercialized.
-
The company has a global presence apart from presence in major cities in India with 36+ sales & service centers and 100+ Channel Partners.
-
The company exports to Africa, Japan, Middle East, Russia, South East Asia, Europe, UK, USA, Canada and neighbouring countries.
FY21 REVENUE BREAKUP*
==> picture [147 x 126] intentionally omitted <==
----- Start of picture text -----
Chemicals
30%
Engineering Engineering
63% 58%
Consumer
Products
7%
----- End of picture text -----
FY21 GEOGRAPHICAL BREAKUP*
==> picture [116 x 116] intentionally omitted <==
----- Start of picture text -----
Domestic Exports
42%
58%
----- End of picture text -----
*Consolidated
3
Q4- FY21 / FY21 Financial Highlights
Q4-FY21 Performance (Standalone)
INR 4,329 Mn INR 801 Mn 18.50% Operating Income Operating EBITDA Operating EBITDA Margins INR 628 Mn 14.51% INR 51.11/Share Net Profit PAT Margins Diluted EPS
FY21 Performance (Standalone)
INR 14,018 Mn INR 1,951 Mn 13.92% Operating Income Operating EBITDA Operating EBITDA Margins INR 1,460 Mn 10.42% INR 118.75/Share Net Profit PAT Margins Diluted EPS
Q4-FY21 Performance (Consolidated)
INR 4,452 Mn INR 857 Mn 19.25% Operating Income Operating EBITDA Operating EBITDA Margins INR 705 Mn 15.84% INR 59.17/Share Net Profit PAT Margins Diluted EPS
FY21 Performance (Consolidated)
INR 14,495 Mn INR 2,023 Mn 13.96% Operating Income Operating EBITDA Operating EBITDA Margins INR 1,433 Mn 9.89% INR 121.41/Share Net Profit PAT Margins Diluted EPS
4
Q4 - FY21 Operational Highlights
BUSINESS OPERATIONS
-
Ø The company witnessed steady sequential improvement in the financial performance.
-
Ø Besides dampening the economic recovery, the resurgence of second wave of Covid-19 at the end of the quarter has posed challenges for execution including disruptions in logistics for material movement.
-
Ø There has been an improved opportunity flow from the international markets.
ENGINEERING
-
Ø Flow of orders during the quarter has been steady
-
Ø Whilst execution of the Sri Lanka Project improved during the quarter, frequent COVID related restrictions in the country continue to pose execution challenge.
-
Ø Order execution of other on-going Engineering orders further picked up pace resulting in improved sales and margins.
CHEMICALS
-
Ø Sales and despatches showed continued improvement in this quarter.
-
Ø Margins improved due to higher turnover coupled with operational efficiencies.
CONSUMER PRODUCTS
- Ø Whilst volumes improved in this quarter, it was constrained due to certain segments continuing to remain affected due to restrained economic resumption in key consumer sectors and aftereffects of the COVID lockdown measures and continued social restrictions.
ENGINEERING ORDER BOOK AND PIPELINE (As on 31[st] March, 2021)
Engineering projects^ ~ INR 6,620 Mn
Outstanding Sri Lanka ~ USD 54 Mn
Bid Pipeline ~ INR 60,000 Mn
^Excluding Sri Lanka Order
5
Q4 - FY21 Standalone Income Statement (IND-AS)
| INCOME STATEMENT (INR MN) | Q4-FY21 | Q4-FY20 | Y-o-Y | Q3-FY21 | Q-o-Q | |
|---|---|---|---|---|---|---|
| Operating Income | 4,329 | 3,279 | 32.0% | 3,338 | 29.7% | |
| Expenses | 3,528 | 2,952 | 19.5% | 2,917 | 20.9% | |
| Operating EBITDA | 801 | 327 | 145.0% | 421 | 90.3% | |
| Operating EBITDA Margins (%) | 18.50% | 9.97% | 853 Bps | 12.61% | 589 Bps | |
| Depreciation | 63 | 61 | 3.3% | 66 | (4.5)% | |
| Finance Cost | 20 | 32 | (37.5)% | 21 | (4.8)% | |
| Other Income | 100 | 155 | (35.5)% | 95 | 5.3% | |
| PBT | 818 | 389 | 110.3% | 429 | 90.7% | |
| Tax | 190 | 100 | 90.0% | 122 | 55.7% | |
| Profit After Tax | 628 | 289 | 117.3% | 307 | 104.6% | |
| PAT Margins (%) | 14.51% | 8.81% | 570 Bps | 9.20% | 531 Bps | |
| Other Comprehensive Income | 17 | (5) | NA | (3) | NA | |
| Total Comprehensive Income | 645 | 284 | 127.1% | 304 | 112.2% | |
| Diluted EPS (INR) | 51.11^ | 23.49# | 117.6% | 24.94# | 104.9% | |
| #Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts. No. of Shares- 23,68,939 |
^Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts (No. of Shares- 23,68,939) and HMIL Shareholding (Staff Welfare) Trusts (No. of Shares – 4,675) |
6
Segmental Breakup - Quarterly Standalone
ENGINEERING (INR MN)
==> picture [223 x 23] intentionally omitted <==
----- Start of picture text -----
CHEMICALS (INR MN)
----- End of picture text -----
CONSUMER PRODUCTS (INR MN)
==> picture [171 x 111] intentionally omitted <==
----- Start of picture text -----
R 2,844
E 2,055
V
E
N
U
E
Q4-FY20 Q4-FY21
----- End of picture text -----
==> picture [113 x 97] intentionally omitted <==
----- Start of picture text -----
1,241
1,013
Q4-FY20 Q4-FY21
----- End of picture text -----
==> picture [112 x 107] intentionally omitted <==
----- Start of picture text -----
377
322
Q4-FY20 Q4-FY21
----- End of picture text -----
==> picture [629 x 117] intentionally omitted <==
----- Start of picture text -----
456 364
Q4-FY20 Q4-FY21
E 241
B
165
I
T
(14)
Q4-FY20 Q4-FY21 Q4-FY20 Q4-FY21
(29)
----- End of picture text -----
7
FY21 Standalone Income Statement (IND-AS)
| INCOME STATEMENT (INR MN) | FY21 | FY20 | Y-o-Y |
|---|---|---|---|
| Operating Income | 14,018 | 14,072 | (0.4)% |
| Expenses | 12,067 | 12,862 | (6.2)% |
| Operating EBITDA | 1,951 | 1,210 | 61.2% |
| Operating EBITDA Margins (%) | 13.92% | 8.60% | 532 Bps |
| Depreciation | 261 | 221 | 18.1% |
| Finance Cost | 99 | 132 | (25.0)% |
| Other Income | 368 | 485 | (24.1)% |
| PBT | 1,959 | 1,342 | 46.0% |
| Tax | 499 | 351 | 42.2% |
| Profit After Tax | 1,460 | 991 | 47.3% |
| PAT Margins (%) | 10.42% | 7.04% | 338 Bps |
| Other Comprehensive Income | 9 | (9) | NA |
| Total Comprehensive Income | 1,469 | 982 | 49.6% |
| Diluted EPS (INR) | 118.75^ | 81.85# | 45.1% |
| #Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts. No. of Shares- 23,68,939 |
^Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts (No. of Shares- 23,68,939 ) and HMIL Shareholding (Staff Welfare) Trusts (No. of Shares – 4,675) |
8
Segmental Breakup – Standalone
ENGINEERING (INR MN) CHEMICALS (INR MN)
CONSUMER PRODUCTS (INR MN)
==> picture [391 x 110] intentionally omitted <==
----- Start of picture text -----
R
8,919 9,027 4,431
E 4,298
V
E
N
U
E
FY20 FY21 FY20 FY21
----- End of picture text -----
==> picture [103 x 89] intentionally omitted <==
----- Start of picture text -----
1,256
1,084
FY20 FY21
----- End of picture text -----
==> picture [625 x 109] intentionally omitted <==
----- Start of picture text -----
864 1,059 FY20 FY21
759
E 608
B
I
T
(41)
Q4-FY20 Q4-FY21 Q4-FY20 Q4-FY21
(71)
----- End of picture text -----
9
Q4 - FY21 Consolidated Income Statement (IND-AS)
| INCOME STATEMENT (INR MN) | Q4-FY21 | Q4-FY21 | Q4-FY20 | Y-o-Y | Q3-FY21 | Q-o-Q | Q-o-Q |
|---|---|---|---|---|---|---|---|
| Operating Income | 4,452 | 3,511 | 26.8% | 3,492 | 27.5% | ||
| Expenses | 3,595 | 3,118 | 15.3% | 3,047 | 18.0% | ||
| Operating EBITDA | 857 | 393 | 118.2% | 445 | 92.6% | ||
| Operating EBITDA Margins (%) | 19.25% | 11.19% | 806 Bps | 12.74% | 651 | Bps | |
| Depreciation | 66 | 64 | 3.1% | 70 | (5.7)% | ||
| Finance Cost | 28 | 40 | (30.0)% | 27 | 3.7% | ||
| Other Income | 138 | 109 | 26.6% | 64 | 115.6% | ||
| PBT | 901 | 398 | 126.6% | 412 | 118.7% | ||
| Share of Profit of equity accounted Investee | (3) | (4) | NA | (1) | NA | ||
| Tax | 193 | 105 | 83.8% | 124 | 55.6% | ||
| Profit After Tax | 705 | 289 | 143.9% | 287 | 145.6% | ||
| PAT Margins (%) | 15.84% | 8.23% | 761 Bps | 8.22% | 762 | Bps | |
| Other Comprehensive Income | 22 | 13 | 69.2% | (14) | NA | ||
| Total Comprehensive Income | 727 | 302 | 140.7% | 273 | 166.3% | ||
| Diluted EPS (INR) | 59.17^ | 24.03# | 146.2% | 24.57# | 140.8% | ||
| #Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff | ^Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts (No. of | ||||||
| Welfare) Trusts (No. of Shares-23,68,939) and shares held by Subsidiary companies (No. of | _Shares-23,68,939), shares held by _ | _Subsidiary companies (No. of Shares- 4,37,874) and HMIL _ | Shareholding (Staff | ||||
| Shares- 4,37,874) | Welfare) Trusts (No. of Shares – 4,675) | 10 |
Segmental Breakup - Quarterly Consolidated
ENGINEERING (INR MN)
==> picture [223 x 23] intentionally omitted <==
----- Start of picture text -----
CHEMICALS (INR MN)
----- End of picture text -----
CONSUMER PRODUCTS (INR MN)
==> picture [395 x 111] intentionally omitted <==
----- Start of picture text -----
R 2,910
1,298
E 2,198
V
1,102
E
N
U
E
Q4-FY20 Q4-FY21 Q4-FY20 Q4-FY21
----- End of picture text -----
==> picture [112 x 104] intentionally omitted <==
----- Start of picture text -----
377
323
Q4-FY20 Q4-FY21
----- End of picture text -----
==> picture [628 x 107] intentionally omitted <==
----- Start of picture text -----
557
389 Q4-FY20 Q4-FY21
E
264 224
B
I
T (14)
Q4-FY20 Q4-FY21 Q4-FY20 Q4-FY21 (28)
----- End of picture text -----
11
FY21 Consolidated Income Statement (IND-AS)
| INCOME STATEMENT (INR MN) | FY21 | FY20 | Y-o-Y | |
|---|---|---|---|---|
| Operating Income | 14,495 | 14,798 | (2.0)% | |
| Expenses | 12,472 | 13,453 | (7.3)% | |
| Operating EBITDA | 2,023 | 1,345 | 50.4% | |
| Operating EBITDA Margins (%) | 13.96% | 9.09% | 487 Bps | |
| Depreciation | 277 | 235 | 17.7% | |
| Finance Cost | 126 | 160 | (21.3)% | |
| Other Income | 331 | 354 | (6.5)% | |
| PBT | 1,951 | 1,304 | 49.6% | |
| Share of Profit of equity accounted investee | (1) | 5 | NA | |
| Tax | 517 | 367 | 40.9% | |
| Profit After Tax | 1,433 | 942 | 52.1% | |
| PAT Margins (%) | 9.89% | 6.37% | 352 Bps | |
| Other Comprehensive Income | (2) | 2 | NA | |
| Total Comprehensive Income | 1,431 | 944 | 51.6% | |
| Diluted EPS (INR) | 121.41^ | 80.22# | 51.3% | |
| #Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts (No. of Shares-23,68,939) and shares held by Subsidiary companies (No. of Shares- 4,37,874) |
^Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts (No. of Shares-23,68,939), shares held by Subsidiary companies (No. of Shares- 4,37,874) and HMIL Shareholding (Staff Welfare) Trusts (No. of Shares – 4,675) |
|||
12
Segmental Breakup - Consolidated
ENGINEERING (INR MN) CHEMICALS (INR MN)
==> picture [167 x 110] intentionally omitted <==
----- Start of picture text -----
R 9,386 9,407
E
V
E
N
U
E
FY20 FY21
----- End of picture text -----
==> picture [101 x 94] intentionally omitted <==
----- Start of picture text -----
4,689
4,396
FY20 FY21
----- End of picture text -----
==> picture [390 x 104] intentionally omitted <==
----- Start of picture text -----
995 1,062
771
E 734
B
I
T
FY20 FY21 FY20 FY21
----- End of picture text -----
CONSUMER PRODUCTS (INR MN)
==> picture [102 x 93] intentionally omitted <==
----- Start of picture text -----
1,257
1,084
FY20 FY21
----- End of picture text -----
==> picture [102 x 102] intentionally omitted <==
----- Start of picture text -----
FY20 FY21
(37)
(70)
----- End of picture text -----
13
HISTORICAL FINANCIAL OVERVIEW
14
Standalone Income Statement (IND-AS)
| INCOME STATEMENT (INR MN) | FY18 | FY19 | FY20 | FY21 |
|---|---|---|---|---|
| Operating Income | 9,943 | 11,023 | 14,072 | 14,018 |
| Expenses | 9,239 | 10,110 | 12,862 | 12,067 |
| Operating EBITDA | 704 | 913 | 1,210 | 1,951 |
| Operating EBITDA Margins (%) | 7.08% | 8.28% | 8.60% | 13.92% |
| Depreciation | 119 | 181 | 221 | 261 |
| Finance Cost | 157 | 162 | 132 | 99 |
| Other Income | 300 | 441 | 485 | 368 |
| PBT | 728 | 1,011 | 1,342 | 1,959 |
| Tax | 250 | 345 | 351 | 499 |
| Profit After Tax | 478 | 666 | 991 | 1,460 |
| PAT Margins (%) | 4.80% | 6.04% | 7.04% | 10.42% |
| Other Comprehensive Income | (2) | (5) | (9) | 9 |
| Total Comprehensive Income | 476 | 661 | 982 | 1,469 |
| Diluted EPS (INR) | 39.78* | 55.47* | 81.85# | 118.75^ |
| *Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff _^Earnings per equity share includes impact _ |
of equity shares held by IEI Shareholding (Staff | |||
| Welfare) Trusts. No. of Shares- 26,62,914 | Welfare) Trusts (No. of Shares- 23,68,939 ) and HMIL Shareholding (Staff Welfare) Trusts (No. of | |||
| #Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Shares - 4,675) |
||||
| Welfare) Trusts. No. of Shares- 23,68,939 |
15
Financials - Standalone
==> picture [700 x 346] intentionally omitted <==
----- Start of picture text -----
REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN)
3 Year 3 Year 3 Year
14,072 14,018 CAGR 12% 1,951 CAGR 40% CAGR 45%
1,460
11,023 1,210
9,943 913 991
704
666
478
FY18 FY19 FY20 FY21
FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21
NET DEBT/EQUITY ROE and ROCE WORKING CAPITAL DAYS
FY18 FY19 FY20 FY21 66
26.1%
20.6% 54
17.8% 23.3% 45
15.2%
17.9%
16.5%
13.5%
(0.4)
7
(0.6) (0.6)
FY18 FY19 FY20 FY21
(0.8) ROE ROCE
FY18 FY19 FY20 FY21
ROE = Net Profit/Net worth, ROCE = EBIT/Capital Employed
----- End of picture text -----
16
Standalone Balance Sheet (IND-AS)
| PARTICULARS (INR MN) | FY19 | FY20 | FY21 | PARTICULARS (INR MN) | FY19 | FY20 | FY21 |
|---|---|---|---|---|---|---|---|
| EQUITIES & LIABILITIES | ASSETS | ||||||
| Equity | Non-Current Assets | ||||||
| (A) Equity Share Capital | 147 | 147 | 147 | (A) Property, Plant and Equipment | 1,425 | 1,385 | 1,421 |
| (B) Other Equity | 3,597 | 4,668 | 6,123 | (B) Capital Work-in-progress | 123 | 115 | 146 |
| Total Equity | 3,744 | 4,815 | 6,270 | (C) Right-of-Use Assets | - | 368 | 298 |
| Non-Current Liabilities | (D) Other Intangible Assets | 14 | 16 | 22 | |||
| (A) Financial Liabilities | (E) Financial Assets | ||||||
| (i) Borrowings | 261 | 187 | 79 | (i) Investments | 607 | 620 | 625 |
| (ii) Lease Liabilities | - | 101 | 46 | (ii) Trade Receivables | 36 | 29 | 12 |
| (iii) Other financial Liabilities | 81 | 81 | 85 | (iii) Loans | 403 | 420 | 420 |
| (B) Provisions | 118 | 140 | 148 | (F) Other Non-Current Assets | 63 | 54 | 35 |
| (C) Deferred Tax Liabilities (Net) | 11 | - | - | (G) Deferred Tax Assets | - | 6 | 42 |
| (D) Liabilities for Non-Current Tax (Net) | 15 | 19 | - | Total Non – Current Assets | 2,671 | 3,013 | 3,021 |
| Total Non – Current Liabilities | 486 | 528 | 358 | Current Assets | |||
| Current Liabilities | (A) Inventories | 1,092 | 1,180 | 1,024 | |||
| (A) Financial Liabilities | (B) Financial Assets | ||||||
| (i) Borrowings | 434 | 504 | 119 | (i) Investments | 4 | 1 | 2 |
| (ii) Lease Liabilities | - | 95 | 59 | (ii) Trade Receivables | 4,276 | 5,137 | 4,529 |
| (iii) Trade Payables | 3,948 | 4,706 | 5,045 | (iii) Cash & Cash Equivalents | 360 | 846 | 761 |
| (iv) Other Financial Liabilities | 380 | 394 | 371 | (iv) Bank Balances | 2,394 | 2,691 | 4,109 |
| (B) Other Current Liabilities | 2,979 | 3,118 | 2,442 | (v) Loans | 509 | 472 | 537 |
| (C) Provisions | 38 | 49 | 46 | (vi) Other Financial Assets | 184 | 224 | 92 |
| (D) Liabilities for current tax (Net) | 141 | 158 | 246 | (C) Other current assets | 660 | 803 | 881 |
| Total Current Liabilities | 7,920 | 9,024 | 8,328 | Total Current Assets | 9,479 | 11,354 | 11,935 |
| GRAND TOTAL - EQUITIES & LIABILITES | 12,150 | 14,367 | 14,956 | GRAND TOTAL – ASSETS | 12,150 | 14,367 | 14,956 |
17
Consolidated Income Statement (IND-AS)
| INCOME STATEMENT (INR MN) | FY18 | FY19 | FY20 | FY21 |
|---|---|---|---|---|
| Operating Income | 10,549 | 11,623 | 14,798 | 14,495 |
| Expenses | 9,779 | 10,557 | 13,453 | 12,472 |
| Operating EBITDA | 770 | 1,066 | 1,345 | 2,023 |
| Operating EBITDA Margins (%) | 7.30% | 9.17% | 9.09% | 13.96% |
| Depreciation | 131 | 196 | 235 | 277 |
| Finance Cost | 187 | 190 | 160 | 126 |
| Other Income | 211 | 333 | 354 | 331 |
| PBT | 663 | 1,013 | 1,304 | 1,951 |
| Share of Profit of equity accounted Investee | (1) | 5 | 5 | (1) |
| Tax | 263 | 359 | 367 | 517 |
| Profit After Tax | 399 | 659 | 942 | 1,433 |
| PAT Margins (%) | 3.78% | 5.67% | 6.37% | 9.89% |
| Other Comprehensive Income | (14) | 1 | 2 | (2) |
| Total Comprehensive Income | 385 | 660 | 944 | 1,431 |
| EPS Diluted (INR) | 34.46* | 56.99* | 80.22# | 121.41^ |
*Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts (No. of Shares-26,62,914) and shares held by Subsidiary companies (No. of Shares- 4,37,874) #Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts (No. of Shares-23,68,939) and shares held by Subsidiary companies (No. of Shares- 4,37,874)
^Earnings per equity share includes impact of equity shares held by IEI Shareholding (Staff Welfare) Trusts (No. of Shares-23,68,939), shares held by Subsidiary companies (No. of Shares- 4,37,874) and HMIL Shareholding (Staff Welfare) Trusts (No of Shares – 4,675)
18
Financials - Consolidated
==> picture [720 x 356] intentionally omitted <==
----- Start of picture text -----
REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN)
REVENUE EBITDA PAT
14,798 14,495 CAGR 11% CAGR 38% CAGR 53%
2,023
1,433
11,623
10,549 1,345
1,066 942
770 659
399
FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21
NET DEBT/ EQUITY ROE and ROCE WORKING CAPITAL DAYS
FY18 FY19 FY20 FY21 70
32.0%
25.3% 25.9% 55
19.90% 28.3%
41
24.5% 24.3%
18.30%
9
(0.6) FY18 FY19 FY20 FY21
(0.8) (0.8) (0.9) ROE ROCE FY18 FY19 FY20 FY21
ROE = Net Profit/Net worth, ROCE = EBIT/Capital
Employed
----- End of picture text -----
19
Consolidated Balance Sheet (IND-AS)
| PARTICULARS (INR MN) | FY19 | FY20 | FY21 | PARTICULARS (INR MN) | FY19 | FY20 | FY21 |
|---|---|---|---|---|---|---|---|
| EQUITIES & LIABILITIES | ASSETS | ||||||
| Equity | Non-Current Assets | ||||||
| (A) Equity Share Capital | 142 | 142 | 142 | (A) Property, Plant and Equipment | 1,507 | 1,459 | 1,486 |
| (B) Other Equity | 2,458 | 3,489 | 4,916 | (B) Capital Work-in-progress | 123 | 115 | 146 |
| Equity attributable to owners | 2,600 | 3,631 | 5,058 | (C) Right-of-Use Assets | - | 379 | 303 |
| Non Controlling Interest | 22 | 20 | (1) | (D) Other Intangible Assets | 14 | 16 | 22 |
| Total Equity | 2,622 | 3,651 | 5,057 | (E) Goodwill | 86 | 86 | 86 |
| (F) Investment accounted using Equity Method | 34 | 37 | 36 | ||||
| Non-Current Liabilities | (G) Financial Assets | ||||||
| (A) Financial Liabilities | (i) Investments | 7 | 7 | 7 | |||
| (i) Borrowings | 261 | 187 | 79 | (ii) Trade Receivables | 142 | 62 | 45 |
| (ii) Lease liabilities | - | 106 | 48 | (iii) Loans | 100 | 118 | 118 |
| (iii) Other Financial Liabilities | 81 | 81 | 85 | (iv) Other Financial Assets | 70 | 65 | 59 |
| (B) Provisions | 133 | 157 | 171 | (H) Deferred Tax Assets (Net) | 10 | 15 | 53 |
| (C) Deferred Tax Liabilities (Net) | 11 | 5 | - | (I) Other Non-Current Assets | 167 | 165 | 136 |
| (D) Other Non-Current Liabilities | 6 | 5 | 5 | (J) Non-Current Tax Assets | 5 | 5 | 6 |
| (E) Liabilities for non-current tax (Net) | 16 | 19 | - | Total Non – Current Assets | 2,265 | 2,529 | 2,503 |
| Total Non – Current Liabilities | 508 | 560 | 388 | Current Assets | |||
| (A) Inventories |
1,298 | 1,345 | 1,276 | ||||
| Current Liabilities | (B) Financial Assets | ||||||
| (A) Financial Liabilities | (i) Investments | 4 | 1 | 2 | |||
| (i) Borrowings | 667 | 723 | 326 | (ii) Trade Receivables | 4,242 | 5,019 | 4,489 |
| (ii) Lease liabilities | - | 97 | 61 | (iii) Cash & Cash Equivalents | 452 | 1,015 | 921 |
| (iii) Trade Payables | 4,151 | 4,936 | 5,353 | (iv) Bank Balances | 2,452 | 2,716 | 4,133 |
| (iv) Other Financial Liabilities | 428 | 438 | 419 | (v) Loans | 91 | 173 | 154 |
| (B) Other Current Liabilities | 3,078 | 3,190 | 2,518 | (vi) Other Financial Assets | 197 | 237 | 106 |
| (C) Provisions | 45 | 56 | 53 | (C) Current Tax Assets (Net) | 13 | 15 | 7 |
| (D) Liabilities for current tax (Net) | 154 | 171 | 258 | (D) Other Current Assets | 639 | 772 | 842 |
| Total Current Liabilities | 8,523 | 9,611 | 8,988 | Total Current Assets | 9,388 | 11,293 | 11,930 |
| GRAND TOTAL - EQUITIES & LIABILITES | 11,653 | 13,822 | 14,433 | GRAND TOTAL – ASSETS | 11,653 | 13,822 | 14,433 |
| 20 |
Market Data (Bloomberg – ION IN, Reuters – IONX.BO)
==> picture [680 x 155] intentionally omitted <==
----- Start of picture text -----
1 YEAR SHARE PRICE MOVEMENT (UP TO 31 [st] MARCH, 2021)
180%
140%
100%
60%
20%
-20%
Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Jan-21 Feb-21 Mar-21
SENSEX ION
----- End of picture text -----
| PRICE DATA (AS ON 31st MARCH, 2021) | SHAREHOLDING PATTERN (AS ON 31st MARCH, 2021) | SHAREHOLDING PATTERN (AS ON 31st MARCH, 2021) | |
|---|---|---|---|
| Face value (INR) | 10.0 | Promoter | |
| Market Price (INR) | 1,306.5 | 27.0% | |
| 52 Week H/L (INR) Market Cap (INR Mn) |
1,495.0/585.0 19,161.3 |
DII 6.8% Others 49.1% |
|
| Equity Shares Outstanding (Mn) | 14.7 | FII | |
| 1 Year Avg. trading volume (‘000) | 34.8 | Employee Trust 16.2% |
0.9% |
21
Disclaimer
Ion Exchange (India) Limited
No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. Certain statements made in this presentation may not be based on historical information or facts and may be "forward looking statements" based on the currently held beliefs and assumptions of the management of Ion Exchange (India) Limited ( “ Company ” or “ IONEX ” ), which are expressed in good faith and in their opinion reasonable, including those relating to the Company ʼ s general business plans and strategy, its future financial condition and growth prospects and future developments in its industry and its competitive and regulatory environment.
Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company or industry results to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements, including future changes or developments in the Company ʼ s business, its competitive environment and political, economic, legal and social conditions. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties and other factors, viewers of this presentation are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements to reflect future events or developments.
This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. This presentation does not constitute an offer or invitation to purchase or subscribe for any securities in any jurisdiction, including the United States. No part of it should form the basis of or be relied upon in connection with any investment decision or any contract or commitment to purchase or subscribe for any securities. None of our securities may be offered or sold in the United States, without registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from registration there from.
This presentation is confidential and may not be copied or disseminated, in whole or in part, and in any manner.
Valorem Advisors Disclaimer:
Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valorem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded.
Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review.
==> picture [81 x 62] intentionally omitted <==
For further details please contact our Investor Relations Representatives: VALOREM ADVISORS
Mr. Anuj Sonpal Tel: +91-22-49039500 Email: [email protected]
22